Yi-miao B. Zhang

Beijing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Safety and efficacy of sirolimus combined with cyclosporine in primary membranous nephropathy: a randomized controlled trial.

Safety and efficacy of sirolimus combined with cyclosporine in primary membranous nephropathy: a randomized controlled trial.

Journal: BMC medicine

Published: February 20, 2025

Multi-omics genetic association analysis identifies susceptibility risk gene of acute viral respiratory infections in multi-ancestry populations and screening of potential traditional Chinese medicines

Multi-omics genetic association analysis identifies susceptibility risk gene of acute viral respiratory infections in multi-ancestry populations and screening of potential traditional Chinese medicines

Journal: Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica

Published: December 19, 2024

The efficacy and safety of rituximab in adult patients with steroid-dependent or frequent relapsing nephrotic syndrome: A retrospective study.

The efficacy and safety of rituximab in adult patients with steroid-dependent or frequent relapsing nephrotic syndrome: A retrospective study.

Journal: International immunopharmacology

Published: November 25, 2024

Anti-nephrin antibodies in adult Chinese patients with minimal change disease and primary focal segmental glomerulosclerosis.

Anti-nephrin antibodies in adult Chinese patients with minimal change disease and primary focal segmental glomerulosclerosis.

Journal: Kidney international

Published: August 21, 2024

Risk factors for relapse and aggravation in membranous nephropathy after COVID-19 infection.

Risk factors for relapse and aggravation in membranous nephropathy after COVID-19 infection.

Journal: BMC nephrology

Published: May 06, 2024

The quantifying relationship between the remission duration and the cardiovascular and kidney outcomes in the patients with primary nephrotic syndrome.

The quantifying relationship between the remission duration and the cardiovascular and kidney outcomes in the patients with primary nephrotic syndrome.

Journal: Renal failure

Published: November 12, 2022

Long-term visit-to-visit variability in low-density lipoprotein cholesterol is associated with poor cardiovascular and kidney outcomes in patients with primary nephrotic syndrome.

Long-term visit-to-visit variability in low-density lipoprotein cholesterol is associated with poor cardiovascular and kidney outcomes in patients with primary nephrotic syndrome.

Journal: International urology and nephrology

Published: January 28, 2022

Effects of hydroxychloroquine on proteinuria in membranous nephropathy.

Effects of hydroxychloroquine on proteinuria in membranous nephropathy.

Journal: Journal of nephrology

Published: June 09, 2021

Rituximab Therapy for Primary Membranous Nephropathy in a Chinese Cohort.

Rituximab Therapy for Primary Membranous Nephropathy in a Chinese Cohort.

Journal: Frontiers in medicine

Published: February 04, 2021

Complement activation profile of patients with primary focal segmental glomerulosclerosis.

Complement activation profile of patients with primary focal segmental glomerulosclerosis.

Journal: PloS one

Published: March 11, 2020

Membranous Nephropathy in Pregnancy.

Membranous Nephropathy in Pregnancy.

Journal: American journal of nephrology

Published: September 22, 2019

Complement activation products in the circulation and urine of primary membranous nephropathy.

Complement activation products in the circulation and urine of primary membranous nephropathy.

Journal: BMC nephrology

Published: June 07, 2018

Showing 1-12 of 27

Last Updated: 09/26/2026